NH-102

N/A

Report date: 2025/01/14 11:38:50
NME

Base Information

Drug NameNH-102
Drug Alias NameNH-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsSerotonin 2a (5-HT2a) receptor antagonists
TargetsDopamine transporterSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive DisorderDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A